This inventor holds 2 USPTO granted patents. Top assignees: Merck + Co., Inc., Merck Sharp + Dohme Corp.. Active years: 2007-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Endicott, NY (US) (2007)
- North Wales, PA (US) (2010)
Company Filing History:
2 out of 4,770 
1 out of 2,405 
Years Active: 2007-2010
Title: The Innovations of Brenda J Mariano: A Pioneer in Cancer Treatment
Introduction: Brenda J Mariano is a notable inventor based in North Wales, PA, who has made significant contributions to the field of medical science. With a focus on treating cellular proliferative diseases, her innovations aim to address serious health conditions, particularly cancer. Her work has led to the development of two important patents that are set to impact the future of cancer therapies.
Latest Patents: Brenda J Mariano holds two patents, both centered around mitotic kinesin inhibitors. Her first patent involves dihydropyrazole compounds, which are designed to treat disorders associated with KSP kinesin activity and inhibit KSP kinesin. These compounds have the potential to be utilized in treatments for various cancers in mammals. The second patent presents dihydropyrrole compounds, which share similar therapeutic purposes and methods of use as the previous invention. Both patents underscore her commitment to advancing cancer treatment through innovative compounds.
Career Highlights: Throughout her career, Brenda has been associated with reputable organizations such as Merck & Company, Inc. and Merck Sharp & Dohme Corporation. Her experience in these prestigious companies has undoubtedly influenced her inventive process and research capabilities. Her focus on groundbreaking therapies has positioned her as a leader in the pharmaceuticals sector specializing in cellular biology and oncology.
Collaborations: Brenda J Mariano has collaborated with talented individuals in her field, including Michael J Breslin and Paul J Coleman. Their joint efforts have contributed to refining her innovations and expanding the impact of her research within the medical community.
Conclusion: Brenda J Mariano exemplifies the spirit of innovation through her dedicated work and substantial contributions to cancer treatment. Her patents on mitotic kinesin inhibitors represent a crucial step forward in developing effective therapies for serious diseases. As her career progresses, there is no doubt that her inventions will continue to inspire new advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile